Benzalkonium chloride/octoxynol vaginal gel - Optima

Drug Profile

Benzalkonium chloride/octoxynol vaginal gel - Optima

Alternative Names: Alkyldimethylbenzylammonium chloride (ADBAC)/octoxynol - Optima; Benzalkonium chloride/octoxynol 9; Contraceptive gel - Optima Worldwide; Octoxynol 9/benzalkonium chloride; Octoxynol/benzalkonium chloride; Prevent-X; Surete

Latest Information Update: 01 Oct 2013

Price : $50

At a glance

  • Originator Optima Worldwide
  • Developer OmniComm Systems; Optima Worldwide
  • Class Antiseptics; Benzylammonium compounds; Contraceptives; Polyethylene glycols; Quaternary ammonium compounds; Spermicidal contraceptives; Surfactants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pregnancy
  • Discontinued HIV infections

Most Recent Events

  • 27 Dec 2000 Phase-III clinical trials for HIV infections prevention in Brazil (Vaginal)
  • 15 Dec 2000 Phase-III clinical trials for Contraception/Pregnancy (Prevention) in Brazil (Vaginal)
  • 22 Nov 2000 Launched for Contraception/Pregnancy (Prevention) in China (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top